The poor dissolution of the relatively insoluble drugs has for long been a problem in the formulation of oral dosage forms. This limits the aspects such as absorption and bioavailability. Similarly the obnoxious taste of unpalatable drug is also not accepted by paediatric and geriatric patients. This problem is more apparent when drinking water is not easily available to the patient taking medicine. Rosuvastatin is poorly water soluble HMG-CoA Reductase inhibitor and in this work Rosuvastatin Orodispersible tablets formulated by preparing inclusion complexation with cyclodextrin for...